Demodex treatment advances, faux-stasis, and how to approach generics entering into the marketplace

Update: 2022-03-29

Description

In this episode Dr Darrell White, Dr Gary Wortz, and Dr Preeya Gupta discuss TP03 for treating demodex and the emergence of demodex as a cofounder in ocular surface disease. And can't miss their take on generic cyclosporine entering the market, its impact on patients and clinicians in addition to learning how not all cyclosporine is the same.

Comments

In Channel

$Weekly Round Up: Refractive Lens Exchange in 2022$

Weekly Round Up: Refractive Lens Exchange in 2022

2022-06-2838:34

Weekly Round Up: the intersection of OSD and glaucoma, neurotrophic keratitis, and practical cataract surgery tips

2022-06-2439:08

Demodex treatment advances, faux-stasis, and how to approach generics entering into the marketplace

2022-03-2942:02

$PRODS (Post Refractive Ophthalmic Dysphoria Syndrome)$

PRODS (Post Refractive Ophthalmic Dysphoria Syndrome)

2022-02-2742:02

Making the leap into private practice

2022-02-0626:22

Lightning Round Episode 3

2022-02-0631:47

The Weekly Round Up: Episode 2

2021-12-2047:15

The Weekly Round Up: Episode 1, the lightening round

2021-12-2027:44

Ergonomics in Ophthalmology: Stand up for yourself

2021-12-2016:38

IPL for dry eye treatment: why we all need to add this into our tool kits

2021-05-2237:13

$Post-operative medication choices in refractive cataract surgery$

Post-operative medication choices in refractive cataract surgery

2021-05-0833:04

How do you successfully run a small practice?

2021-05-0725:01

Treating MGD & DED in a high volume surgical practice

2021-03-1224:57

How to approach anti-inflammatory medications in DED

2021-03-0829:41

What surgeons need to know about optical aberrations as it relates to cataract surgery and IOL selection

2021-03-0727:39

COVID related Dry Eye Disease

2021-03-0730:02

Advanced drug delivery platforms in Ophthalmology: drugs, depots, and inserts

2020-11-0921:54

$A cataract & refractive surgeon's perspective on adopting MIGS$

A cataract & refractive surgeon's perspective on adopting MIGS

2020-11-0218:54

How do I know which in-office MGD treatment will work best for my patient?

2020-10-1920:54

Early experiences with the Hydrus Microstent

2020-10-1927:07

00:00

Demodex treatment advances, faux-stasis, and how to approach generics entering into the marketplace

#box-pro-ellipsis-176082011022872{-webkit-line-clamp:2;}Demodex treatment advances, faux-stasis, and how to approach generics entering into the marketplace

Demodex treatment advances, faux-stasis, and how to approach generics entering into the marketplace

Interventional Mindset

Demodex treatment advances, faux-stasis, and how to approach generics entering into the marketplace